Researchers also are engaged on ultra-very long-performing GLP-one analogs that could call for dosing only once per month or maybe less usually. These prolonged-launch versions could help it become even much easier to stay with having GLP-1s.  Semaglutide imitates the actions of GLP 1 by stimulating insulin production through the pancreatic beta